首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備 DDS

市場調查報告書

商品編碼

1529583

控制釋放藥物傳輸市場：依技術、依治療領域、依應用、按地區

Controlled Release Drug Delivery Market, By Technology, By Therapeutic Area, By Application, By Geography

出版日期: 2024年07月09日 | 出版商:

Coherent Market Insights | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球控制釋放給藥市值為525億美元，預計2031年將達1061億美元，2024年至2031年複合年成長率為10.6%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	525億美元
實際資料	2019-2023	預測期	2024-2031
2024-2031 年預測期複合年成長率	10.60%	2031 年金額預測	1061億美元

圖：控制釋放給藥市場佔有率（%）（2024 年，按地區）

控制釋放藥物遞送有助於在較長的時間內（從幾小時到幾天）遞送藥學活性化合物或藥物。與傳統的藥物遞送相比，它具有減少給藥頻率、提高療效、減少副作用等優點。慢性病盛行率上升、老年人口增加、領先公司研發投資增加以及技術進步等因素正在推動市場成長。然而，與開發控制釋放製劑相關的高成本和嚴格的監管核准流程可能會給市場參與企業帶來挑戰。

市場動態：

全球控制釋放給藥市場的成長是由糖尿病、癌症和心血管疾病等慢性病盛行率上升所推動的。據世界衛生組織稱，2020年，慢性病將佔全球死亡人數的70%以上。控制釋放藥物可以透過長時間維持體內藥物濃度恆定來幫助改善慢性病的治療。更容易患慢性病的老年人口的增加也將成為市場成長的推動力。然而，開發控制釋放製劑的高成本和臨床試驗的時間長可能會阻礙市場成長。控制釋放藥物輸送機制的技術進步、對長效藥物的日益偏好以及專注於開發罕見疾病的特殊藥物可能會為市場參與者提供成長機會。

本研究的主要特點

該報告對全球控制釋放給藥市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。已發布。
它還揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球控制釋放藥物輸送市場的主要企業。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球控制釋放藥物輸送市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於全球控制釋放藥物輸送市場分析的各種策略矩陣來促進他們的決策。

公司簡介
- Orbis Biosciences, Inc.
- Merck and Co., Inc.
- Alkermes plc
- Johnson and Johnson
- Coating Place, Inc.
- Corium International, Inc.
- Depomed, Inc.
- Pfizer, Inc
- Aradigm Corporation
- Capsugel.
- Abbott Laboratories
- Roche Holdings AG
- AstraZeneca
- Baxter International Inc
- Teva Pharmaceutical Industries Ltd.
- Bristol-Myers Squibb Company

第11章分析師建議

上升和下降
綜合機會圖

第12章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI7133

Global controlled release drug delivery market is estimated to be valued at USD 52.5 Bn in 2024 and is expected to reach USD 106.1 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.6% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 52.5 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	10.60%	2031 Value Projection:	US$ 106.1 Bn

Figure.Controlled Release Drug Delivery Market Share (%), By Region 2024

Controlled Release Drug Delivery Market - IMG1

Controlled release delivery mechanism helps in delivering a pharmaceutical active compound or drug over an extended period of time, from hours to days. It offers several advantages over conventional drug delivery such as reduced dosing frequency, better therapeutic effectiveness and lower side effects. Factors such as growing prevalence of chronic diseases, rising geriatric population, increasing R&D investments by major players and technological advancements can drive the market growth. However, high costs associated with developing controlled release products and stringent regulatory approval process can pose challenges for the market players.

Market Dynamics:

Global controlled release drug delivery market growth is driven by rising prevalence of chronic diseases such as diabetes, cancer and cardiovascular diseases. According to the WHO, chronic diseases accounted for over 70% deaths worldwide in 2020. Controlled release drugs help in better management of chronic conditions through constant drug levels in the body over an extended time period. Growing geriatric population prone to chronic illnesses can also drive the market growth. However, high costs associated with developing controlled release formulations and long duration of clinical trials can hamper the market growth. Technological advancements in controlled release drug delivery mechanisms, growing preference for long-acting pharmaceuticals, and focus on developing specialty drugs for orphan diseases can offer growth opportunities for market players.

Key features of the study:

This report provides in-depth analysis of the global controlled release drug delivery market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global controlled release drug delivery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Depomed, Coating Place, Corium, and Johnson and Johnson
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global controlled release drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global controlled release drug delivery market.

Detailed Segmentation-

By Technology
- Wurster Technique
- Coacervation
- Micro Encapsulation
- Transdermal
- Targeted Delivery
- Others
By Therapeutic Area
- Infectious Diseases
- Oncology
- Cardiology
- Neurology
- Autoimmune Diseases
- Others
By Application
- Metered Dose Inhalers
- Injectables
- Infusion Pumps
- Drug Eluting Stents
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Orbis Biosciences, Inc.
- Merck and Co., Inc.
- Alkermes plc
- Johnson and Johnson
- Coating Place, Inc.
- Corium International, Inc.
- Depomed, Inc.
- Pfizer, Inc
- Aradigm Corporation
- Abbott Laboratories
- Roche Holdings AG
- AstraZeneca
- Baxter International Inc
- Teva Pharmaceutical Industries Ltd.
- Bristol-Myers Squibb Company

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Controlled Release Drug Delivery Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Controlled Release Drug Delivery Market, By Technology, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Wurster Technique
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Coacervation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Micro Encapsulation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Transdermal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Targeted Delivery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Controlled Release Drug Delivery Market, By Therapeutic Area, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Infectious Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neurology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Autoimmune Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Controlled Release Drug Delivery Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Metered Dose Inhalers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Injectables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Infusion Pumps
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Drug Eluting Stents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Controlled Release Drug Delivery Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospital Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Controlled Release Drug Delivery Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East

10. Competitive Landscape

Company Profiles
- Orbis Biosciences, Inc.
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck and Co., Inc.
- Alkermes plc
- Johnson and Johnson
- Coating Place, Inc.
- Corium International, Inc.
- Depomed, Inc.
- Pfizer, Inc
- Aradigm Corporation
- Capsugel.
- Abbott Laboratories
- Roche Holdings AG
- AstraZeneca
- Baxter International Inc
- Teva Pharmaceutical Industries Ltd.
- Bristol-Myers Squibb Company